The Scientist

» drug development, ecology and disease/medicine

Most Recent

image: Cuban-U.S. Research Collaborations Easier Now

Cuban-U.S. Research Collaborations Easier Now

By | October 18, 2016

President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.

0 Comments

Once implanted in mice, the edited stem cells produced normal hemoglobin.

0 Comments

image: Deep-Sea Viruses Destroy Archaea

Deep-Sea Viruses Destroy Archaea

By | October 12, 2016

Viruses are responsible for the majority of archaea deaths on the deep ocean floors, scientists show.

4 Comments

image: Pet Meds Adapted from Human Therapies

Pet Meds Adapted from Human Therapies

By | October 1, 2016

Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.

0 Comments

image: Techniques for Assessing Genomic Copy Number Variations

Techniques for Assessing Genomic Copy Number Variations

By | October 1, 2016

As the importance of genomic copy number variations for health and disease becomes clearer, researchers are creating new ways to detect these changes in the genome.

0 Comments

image: Genes Linked to Dogs’ Sociability with People

Genes Linked to Dogs’ Sociability with People

By | September 30, 2016

Genetic variants on chromosome 26 appears to play a role in a dog’s tendency to turn to people for help.

0 Comments

image: Broadly Neutralizing Antibodies in HIV Patients

Broadly Neutralizing Antibodies in HIV Patients

By | September 28, 2016

Researchers identify aspects of the patient, the virus, and the infection itself that influence whether a person with HIV will produce broadly neutralizing antibodies.

0 Comments

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

The National Institutes of Health is hosting a two-day conference on how the virus affects infants and children. The take-home message so far: microcephaly is but one of many potential problems for Zika-exposed fetuses.

0 Comments

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

Popular Now

  1. A Coral to Outlast Climate Change
  2. Science Celebrities: Where Are the Women?
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. Understanding Body Ownership and Agency
AAAS